FDA Cites Florida Drugmaker for Serious Quality Violations

Drug GMP Report
A A
An FDA investigation into serious quality problems at a Florida pharmaceutical company revealed a litany of unsound practices in the manufacture of experimental drugs.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $157.00